• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

双氯芬酸钠控释渗透泵片的研制与生物药剂学评价

Development and biopharmaceutical evaluation of osmotic pump tablets for controlled delivery of diclofenac sodium.

作者信息

Rani Meena, Surana Rahul, Sankar Chelladurai, Mishra Brahmeshwar

机构信息

Department of Pharmaceutics, Institute of Technology, Banaras Hindu University, Varanasi-221005 (U.P.), India.

出版信息

Acta Pharm. 2003 Dec;53(4):263-73.

PMID:14769233
Abstract

Based on the principles of an elementary osmotic pump (OP), OP tablets were designed and evaluated with the aim to deliver diclofenac sodium (DS) in a controlled manner. In vitro evaluation was done in various release media and kinetics was evaluated using the regression coefficient analysis. Effects of orifice size, coating membrane type, coating thickness, static and stirred conditions and pH variation were studied. In vivo evaluation was performed on six healthy human volunteers and various pharmacokinetic parameters (c(max), t(max), AUC(0-24), MRT) and relative bioavailability were calculated. The results were compared with the performance of two commercial tablets of DS. The drug release from OP tablets was dependent on the type and thickness of the coating membrane, but was independent of the orifice size and static and stirred conditions of the release medium. The OP tablets provided a prolonged and controlled DS release compared to commercial sustained-release and conventional tablets of DS.

摘要

基于基本渗透泵(OP)原理,设计并评估了OP片剂,旨在以可控方式递送双氯芬酸钠(DS)。在各种释放介质中进行体外评估,并使用回归系数分析评估动力学。研究了孔口大小、包衣膜类型、包衣厚度、静态和搅拌条件以及pH变化的影响。对六名健康人类志愿者进行体内评估,并计算各种药代动力学参数(c(max)、t(max)、AUC(0-24)、MRT)和相对生物利用度。将结果与两种DS市售片剂的性能进行比较。OP片剂的药物释放取决于包衣膜的类型和厚度,但与孔口大小以及释放介质的静态和搅拌条件无关。与DS的市售缓释片和普通片相比,OP片剂提供了延长且可控的DS释放。

相似文献

1
Development and biopharmaceutical evaluation of osmotic pump tablets for controlled delivery of diclofenac sodium.双氯芬酸钠控释渗透泵片的研制与生物药剂学评价
Acta Pharm. 2003 Dec;53(4):263-73.
2
Development of an osmotic pump system for controlled delivery of diclofenac sodium.用于双氯芬酸钠控释的渗透泵系统的开发。
Drug Discov Ther. 2012 Oct;6(5):269-77.
3
Formulation and in vitro and in vivo availability of diclofenac sodium enteric-coated beads.双氯芬酸钠肠溶包衣微丸的制剂及其体外和体内的生物利用度
Drug Dev Ind Pharm. 1998 Jul;24(7):661-6. doi: 10.3109/03639049809082368.
4
Development and biopharmaceutical evaluation of extended release formulation of tramadol hydrochloride based on osmotic technology.基于渗透技术的盐酸曲马多缓释制剂的研发与生物药剂学评价
Acta Pharm. 2009 Mar;59(1):15-30. doi: 10.2478/v10007-009-0010-2.
5
Formulation and biopharmaceutical evaluation of osmotic matrix tablets of diclofenac sodium.
Drug Deliv. 2004 Jul-Aug;11(4):263-70. doi: 10.1080/10717540490467393.
6
In-vitro and in-vivo evaluation of enteric-coated starch-based pellets prepared via extrusion/spheronisation.通过挤出/滚圆法制备的肠溶包衣淀粉基微丸的体外和体内评价
Eur J Pharm Biopharm. 2008 Sep;70(1):302-12. doi: 10.1016/j.ejpb.2008.04.019. Epub 2008 Apr 29.
7
Comparative in vitro and in vivo evaluation of matrix, osmotic matrix, and osmotic pump tablets for controlled delivery of diclofenac sodium.双氯芬酸钠控释用基质片、渗透型基质片和渗透泵片的体外和体内比较评价
AAPS PharmSciTech. 2004 Aug 20;5(4):e71. doi: 10.1208/pt050471.
8
Evaluation of crosslinked chitosan hydrogel beads as a carrier for prolonged delivery of diclofenac sodium: in vitro and in vivo studies.交联壳聚糖水凝胶珠作为双氯芬酸钠长效递送载体的评价:体内外研究
Boll Chim Farm. 2004 Dec;143(10):359-64.
9
Design, development and in vitro-in vivo study of a colon-specific fast disintegrating tablet.设计、开发和结肠定位速崩片的体内外研究。
Pharm Dev Technol. 2011 Oct;16(5):449-56. doi: 10.3109/10837450.2010.485319. Epub 2010 May 21.
10
Chitosan-based controlled porosity osmotic pump for colon-specific delivery system: screening of formulation variables and in vitro investigation.用于结肠特异性给药系统的壳聚糖基控孔渗透泵:制剂变量筛选及体外研究
Int J Pharm. 2007 Mar 6;332(1-2):115-24. doi: 10.1016/j.ijpharm.2006.09.038. Epub 2006 Sep 29.

引用本文的文献

1
Development and evaluation of microporous osmotic tablets of diltiazem hydrochloride.盐酸地尔硫䓬微孔渗透泵片的研制与评价
J Adv Pharm Technol Res. 2012 Apr;3(2):124-9. doi: 10.4103/2231-4040.97292.
2
Development and optimization of micro/nanoporous osmotic pump tablets.开发和优化微孔/纳米渗透泵片。
AAPS PharmSciTech. 2010 Jun;11(2):924-35. doi: 10.1208/s12249-010-9446-4. Epub 2010 May 25.
3
Comparative in vitro and in vivo evaluation of matrix, osmotic matrix, and osmotic pump tablets for controlled delivery of diclofenac sodium.
双氯芬酸钠控释用基质片、渗透型基质片和渗透泵片的体外和体内比较评价
AAPS PharmSciTech. 2004 Aug 20;5(4):e71. doi: 10.1208/pt050471.